Abstract
Endoscopic eradication therapy is an acceptable strategy for the management of Barrett's esophagus patients with high-grade dysplasia (HGD) or intramucosal adenocarcinoma (IMC). However it is not known if the efficacy of endoscopic therapy on patients with these two distinct histological lesions is different.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
